Literature DB >> 19628305

Endogenous Aβ causes cell death via early tau hyperphosphorylation.

G Amadoro1, V Corsetti, M T Ciotti, F Florenzano, S Capsoni, G Amato, P Calissano.   

Abstract

Alzheimer's disease (AD) is characterized by Aβ overproduction and tau hyperphosphorylation. We report that an early, transient and site-specific AD-like tau hyperphosphorylation at Ser262 and Thr231 epitopes is temporally and causally related with an activation of the endogenous amyloidogenic pathway that we previously reported in hippocampal neurons undergoing cell death upon NGF withdrawal [Matrone, C., Ciotti, M.T., Mercanti, D., Marolda, R., Calissano, P., 2008b. NGF and BDNF signaling control amyloidogenic route and Ab production in hippocampal neurons. Proc. Natl. Acad. Sci. 105, 13138-13143]. Such tau hyperphosphorylation, as well as apoptotic death, is (i) blocked by 4G8 and 6E10 Aβ antibodies or by specific β and/or γ-secretases inhibitors; (ii) temporally precedes tau cleavage mediated by a delayed (6-12h after NGF withdrawal) activation of caspase-3 and calpain-I; (iii) under control of Akt-GSK3β-mediated signaling. Finally, we show that such site-specific tau hyperphosphorylation causes tau detachment from microtubules and an impairment of mitochondrial trafficking. These results depict, for the first time, a rapid interplay between endogenous Aβ and tau post-translational modifications which act co-ordinately to compromise neuronal functions in the same neuronal system, under physiological conditions as seen in AD brain.
Copyright © 2009 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19628305     DOI: 10.1016/j.neurobiolaging.2009.06.005

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  35 in total

Review 1.  Is the mitochondrial outermembrane protein VDAC1 therapeutic target for Alzheimer's disease?

Authors:  P Hemachandra Reddy
Journal:  Biochim Biophys Acta       Date:  2012-09-17

2.  Protective effects of humanin on okadaic Acid-induced neurotoxicities in cultured cortical neurons.

Authors:  Jinfeng Zhao; Dan Wang; Lingmin Li; Wenhui Zhao; Ce Zhang
Journal:  Neurochem Res       Date:  2014-08-21       Impact factor: 3.996

Review 3.  Tau acts as a mediator for Alzheimer's disease-related synaptic deficits.

Authors:  Dezhi Liao; Eric C Miller; Peter J Teravskis
Journal:  Eur J Neurosci       Date:  2014-04       Impact factor: 3.386

Review 4.  Abnormal tau, mitochondrial dysfunction, impaired axonal transport of mitochondria, and synaptic deprivation in Alzheimer's disease.

Authors:  P Hemachandra Reddy
Journal:  Brain Res       Date:  2011-07-31       Impact factor: 3.252

5.  Tau Ser262 phosphorylation is critical for Abeta42-induced tau toxicity in a transgenic Drosophila model of Alzheimer's disease.

Authors:  Koichi Iijima; Anthony Gatt; Kanae Iijima-Ando
Journal:  Hum Mol Genet       Date:  2010-05-12       Impact factor: 6.150

6.  Mitochondrial superoxide contributes to blood flow and axonal transport deficits in the Tg2576 mouse model of Alzheimer's disease.

Authors:  Cynthia A Massaad; Samir K Amin; Lingyun Hu; Yuan Mei; Eric Klann; Robia G Pautler
Journal:  PLoS One       Date:  2010-05-10       Impact factor: 3.240

7.  Protein aggregation containing β-amyloid, α-synuclein and hyperphosphorylated τ in cultured cells of hippocampus, substantia nigra and locus coeruleus after rotenone exposure.

Authors:  Rodrigo S Chaves; Thaiany Q Melo; Stephanie A Martins; Merari F R Ferrari
Journal:  BMC Neurosci       Date:  2010-11-10       Impact factor: 3.288

8.  Increased tau phosphorylation and cleavage in mouse models of type 1 and type 2 diabetes.

Authors:  Bhumsoo Kim; Carey Backus; Sangsu Oh; John M Hayes; Eva L Feldman
Journal:  Endocrinology       Date:  2009-10-09       Impact factor: 4.736

9.  Increased tauopathy drives microglia-mediated clearance of beta-amyloid.

Authors:  Wesley Chen; Edsel A Abud; Stephen T Yeung; Anita Lakatos; Trevor Nassi; Jane Wang; David Blum; Luc Buée; Wayne W Poon; Mathew Blurton-Jones
Journal:  Acta Neuropathol Commun       Date:  2016-06-23       Impact factor: 7.801

10.  Rotenone-dependent changes of anterograde motor protein expression and mitochondrial mobility in brain areas related to neurodegenerative diseases.

Authors:  Thaiany Q Melo; Aline M D'unhao; Stephanie A Martins; Karen L G Farizatto; Rodrigo S Chaves; Merari F R Ferrari
Journal:  Cell Mol Neurobiol       Date:  2012-12-22       Impact factor: 5.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.